TrialBMC cardiovascular disorders2026

Evaluation of safety and affection of variable duration of dual antiplatelet therapy using aspirin plus ticagrelor after successful percutaneous coronary intervention for diabetic patients with acute coronary syndrome.

Nour Eldeen Mahmoud Shabaan Ibrahim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.